Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 927-806-3 | CAS number: 1302-69-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-07-07 - 2009-07-21
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Category Hypothesis
This category covers Spinel Type Minerals: The spinels are any of a class of minerals of the general chemical formula XY2O4 which crystallize into the cubic (isometric) crystal system, with the oxide anions arranged in a cubic close-packed lattice and the cations X and Y occupying some or all of the octahedral and tetrahedral sites in the lattice. X and Y can be divalent, trivalent or quadrivalent cations.
Through appropriate physical-chemical characterization of these various minerals it is possible to form one category from the Spinel Type Minerals MgAl2O4 (“Spinel”), FeAl2O4 (“Hercynite”), MnAl2O4 (“Galaxite”) and Pleonaste (iron rich spinel).
Even though such inorganic Spinel Type Minerals contain one or more than one heavy metal, the oxides of which may be potentially toxic and may cause toxic effects, these heavy metals in the Spinel Type Minerals behave differently from their oxides due to the special, i.e. spinel type, crystal matrix/structure.
Therefore, an appropriate toxicological evaluation of these inorganic Spinel Type Minerals can not be based on the properties of the isolated metal oxide(s).
This is due to the fact, that the heavy metals are so firmly bound within the spinel type lattice that they do lack any relevant solubility which is a precondition for any bioavailability.
This was in particular confirmed by solubility tests in (lung) surfactant and saliva/gastric/small intestine fluids.
A literature survey (see under assessment reports) describes and confirms an adequate and plausible description of the obvious biological inertness of Spinel Type Minerals.
Category justification
All Spinel Type Minerals comprise a spinel crystal structure which is devoid of any (practically relevant) water solubility and which is further characterized by very high melting points.
Spinel Type Minerals are also not bioavailable in vivo, which was confirmed by in vitro solubility tests in (lung) surfactant and saliva/gastric/small intestine fluids.
The Spinel Type Minerals are not skin and eye irritating in conducted in vitro tests which further confirms their biological inertness.
Their behaviour in water and biological systems is dominated by their insolubility and missing bioavailability. They constitute in general practically inert materials also with regard to their content of heavy metals. Thus, they also do not contribute to any ecological hazards.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- Relative humidity in the animal room was between 45-100% for few hours.
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 1302-67-6
- Cas Number:
- 1302-67-6
- IUPAC Name:
- 1302-67-6
- Reference substance name:
- Spinel (Mg(AlO2)2)
- EC Number:
- 215-105-9
- EC Name:
- Spinel (Mg(AlO2)2)
- Cas Number:
- 1302-67-6
- Molecular formula:
- AlO2.1/2Mg
- IUPAC Name:
- 215-105-9
- Reference substance name:
- magnesium dialuminium oxide
- IUPAC Name:
- magnesium dialuminium oxide
- Details on test material:
- Batch no.: SP-AR78-20MY, batch 0825193518
Purity: > 99%
Expiration date: unlimited stability
Constituent 1
Constituent 2
Constituent 3
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
Study design: in vivo (LLNA)
- Vehicle:
- dimethylformamide
- Concentration:
- 10, 25, 50 %
- No. of animals per dose:
- 4
- Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- Experiment performed in June 2009.
Positive control substance: alpha-Hexylcinnamaldehyde
Vehicle: acetone:olive oil (4+1)
Test item concentration % (w/v) Group Measurement DPM DPM-BG a) number of lymph nodes DPM per lymph node b) S.I.
--- BG I 23 --- --- --- ---
--- BG II 19 --- --- --- ---
0 1 5842 5821 8 727.6
5 2 10450 10429 8 1303.6 1.79
10 3 12168 12147 8 1518.4 2.09
25 4 39834 39813 8 4976.6 6.84
BG = Background (1 ml 5% trichloroacetic acid) in duplicate
1 = Control Group
2-4 = Test Group
S.I. = Stimulation Index
a) = The mean value was taken from the figures BG I and BG II
b) = Since the lymph nodes of the animals of a dose group were pooled, DPM/node was determined by dividing the measured value by the number of lymph nodes pooled
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 1.17
- Test group / Remarks:
- 2
- Remarks on result:
- other:
- Parameter:
- SI
- Value:
- 1.88
- Test group / Remarks:
- 3
- Parameter:
- SI
- Value:
- 1.42
- Test group / Remarks:
- 4
Any other information on results incl. tables
Test item concentration % (w/w) |
Group |
Measurement DPM |
Calculation |
Result |
||
DPM-BGa) |
number of lymph nodes |
DPM per lymph nodeb) |
S.I. |
|||
--- |
BG I |
29 |
--- |
--- |
--- |
--- |
--- |
BG II |
26 |
--- |
--- |
--- |
--- |
--- |
1 |
4932 |
4905 |
8 |
613.1 |
|
10 |
2 |
5770 |
5743 |
8 |
717.8 |
1.17 |
25 |
3 |
9240 |
9213 |
8 |
1151.6 |
1.88 |
50 |
4 |
6996 |
6969 |
8 |
871.1 |
1.42 |
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
Justification for read-across:
Spinel type minerals all have a spinel crystal structure, no water solubility and high melting points.
Their behaviour in water and biological systems is dominated by their insolubility and missing bioavailability. They constitute in general practically inert materials also regard to their content of heavy metals. Thus, they to not contribute to any ecological hazards.
They are also not bioavailable in vivo, which was confirmed by solubility tests in surfactant and stomach/small intestine fluids.
The Spinel type minerals are not skin irritating and not eye irritating in the conducted in vitro tests.
Physico-chemical properties of Spinel and Galaxite:
Spinel Galaxite
density (g/cm3): 3.55 4.23
melting-point (°C): 2135 1720
water-solubility: insoluble insoluble
bioavailability in the digestive tract: not bioavailable not bioavailable
bioavailability in the lung: not bioavailable not bioavailable
Conclusions:
Applying read-across it can be assumed that Galaxite is not a skin sensitiser.- Executive summary:
Justification for read-across:
Spinel type minerals all have a spinel crystal structure, no water solubility and high melting points. Their behaviour in water and biological systems is dominated by their insolubility and missing bioavailability. They constitute in general practically inert materials also regard to their content of heavy metals. Thus, they to not contribute to any ecological hazards. They are also not bioavailable in vivo, which was confirmed by solubility tests in surfactant and stomach/small intestine fluids. The Spinel type minerals are not skin irritating and not eye irritating in the conducted in vitro tests.
Physico-chemical properties of Spinel and Galaxite:
Spinel Galaxite density (g/cm3) 3.55 4.23 melting-point (degree C) 2,135 1,720 water-solubility insoluble insoluble bioavailability in the digestive tract not bioavailable not bioavailable bioavailability in the lung not bioavailable not bioavailable
crystal structure spinel lattice spinel lattice Conclusions:
In order to study a possible contact allergenic potential of Spinel, three groups each of four female mice were treated daily with the test item at concentrations of 10, 25, and 50% (w/w) in dimethylformamide by topical application to the dorsum of each ear lobe (left and right) for three consecutive days. A control group of four mice was treated with the vehicle (dimethylformamide) only. Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H-methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes, which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of3H-methyl thymidine measured in ab-scintillation counter.
All treated animals survived the scheduled study period and no signs of toxicity were observed.
A test item is regarded as a sensitiser in the LLNA if the exposure to one or more test concentration resulted in 3-fold or greater increase in incorporation of3HTdR compared with concurrent controls, as indicated by the Stimulation Index (S.I.). The estimated concentration of test item required to produce a S.I. of 3 is referred to as the EC3 value.
In this study Stimulation Indices of 1.17, 1.88, and 1.42 were determined with the test item at concentrations of 10, 25, and 50% in dimethylformamide. The EC3 value could not be calculated, since none of the tested concentrations induced an S.I. greater than 3.
Applying read-across it can be assumed that Galaxite is not a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
